申请人:Gilead Sciences, Inc.
公开号:US20150361095A1
公开(公告)日:2015-12-17
The present application provides the compounds of formula (J),
or pharmaceutically acceptable salts, isomers, or a mixture thereof, wherein n, m, q, A′, W
1
, W
2
, W
3
, R
1
, R
2
, and R
3
are described herein. The compounds are inhibitors to the activities of phosphatidylinositol 3-kinase (PI3K) and are useful for treating conditions mediated by one or more PI3K isoforms. The present application further provides pharmaceutical compositions that include a compound of formula (J), or pharmaceutically acceptable salts, isomers, tautomer, or mixture thereof, and methods of using these compounds and compositions for treating conditions mediated by one or more PI3K isoforms.
本申请提供了化合物的公式(J),或其药用盐、异构体或其混合物,其中n、m、q、A'、W1、W2、W3、R1、R2和R3如本文所述。这些化合物是磷脂酰肌醇3-激酶(PI3K)活性的抑制剂,可用于治疗由一个或多个PI3K同工型介导的疾病。本申请还提供了包括公式(J)化合物、药用盐、异构体、互变异构体或其混合物的药物组合物,以及使用这些化合物和组合物治疗由一个或多个PI3K同工型介导的疾病的方法。